Aytu BioScience logo
Aytu BioScience AYTU
$ 2.66 0.0%
report update icon

Quarterly report 2027-Q1
added 11-16-2026

Aytu BioScience Total Current Liabilities | AYTU

Annual Total Current Liabilities Aytu BioScience

2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005
54.7 M 63.1 M 62.2 M 69 M 64.4 M 109 M 28.3 M 5.37 M 3.39 M 3.61 M 10.1 M 1.48 M - 121 K 82.4 K - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
109 M 82.4 K 34 M

Total Current Liabilities of other stocks in the Biotechnology industry

Issuer Total Current Liabilities Price % 24h Market Cap Country
Seres Therapeutics Seres Therapeutics
MCRB
19.3 M $ 1.25 -6.02 % $ 11.1 M usaUSA
Oramed Pharmaceuticals Oramed Pharmaceuticals
ORMP
19.1 M $ 3.58 -2.98 % $ 148 M israelIsrael
Madrigal Pharmaceuticals Madrigal Pharmaceuticals
MDGL
310 M $ 378.19 -4.68 % $ 8.48 B usaUSA
CEL-SCI Corporation CEL-SCI Corporation
CVM
5.13 M $ 1.2 -18.37 % $ 9.62 M usaUSA
MeiraGTx Holdings plc MeiraGTx Holdings plc
MGTX
123 M $ 7.98 -1.97 % $ 642 M usaUSA
Teva Pharmaceutical Industries Limited Teva Pharmaceutical Industries Limited
TEVA
13.5 B $ 39.21 1.76 % $ 44.9 B israelIsrael
Eton Pharmaceuticals Eton Pharmaceuticals
ETON
38.5 M $ 60.77 -0.96 % $ 1.64 B usaUSA
IDEAYA Biosciences IDEAYA Biosciences
IDYA
58.8 M $ 25.52 -2.48 % $ 2.26 B usaUSA
Protalix BioTherapeutics Protalix BioTherapeutics
PLX
26.5 M $ 2.89 -5.56 % $ 227 M israelIsrael
Lantern Pharma Lantern Pharma
LTRN
4.5 M $ 0.25 -13.67 % $ 2.72 M usaUSA
Foghorn Therapeutics Foghorn Therapeutics
FHTX
59.7 M $ 1.71 -3.93 % $ 108 M usaUSA
Ocugen Ocugen
OCGN
23 M $ 0.77 4.74 % $ 241 M usaUSA
Minerva Neurosciences Minerva Neurosciences
NERV
2.29 M $ 2.03 -4.25 % $ 17.2 M usaUSA
Neurocrine Biosciences Neurocrine Biosciences
NBIX
743 M $ 150.5 -3.89 % $ 15 B usaUSA
Prothena Corporation plc Prothena Corporation plc
PRTA
40.8 M $ 8.12 -3.33 % $ 437 M usaUSA
Maravai LifeSciences Holdings Maravai LifeSciences Holdings
MRVI
44.9 M $ 6.99 -2.85 % $ 1.01 B usaUSA
Lexicon Pharmaceuticals Lexicon Pharmaceuticals
LXRX
20.9 M $ 1.53 -8.68 % $ 555 M usaUSA
Moleculin Biotech Moleculin Biotech
MBRX
6.85 M $ 7.73 -2.59 % $ 9.16 M usaUSA
Nurix Therapeutics Nurix Therapeutics
NRIX
86.5 M $ 12.88 -5.29 % $ 1.12 B usaUSA
Nkarta Nkarta
NKTX
22.3 M $ 1.14 1.34 % $ 84.3 M usaUSA
MacroGenics MacroGenics
MGNX
43.1 M $ 1.97 -0.76 % $ 124 M usaUSA
Protagonist Therapeutics Protagonist Therapeutics
PTGX
45.4 M $ 121.72 -2.2 % $ 7.74 B usaUSA
Marker Therapeutics Marker Therapeutics
MRKR
2.27 M $ 1.1 -17.05 % $ 16.8 M usaUSA
Arcus Biosciences Arcus Biosciences
RCUS
231 M $ 15.62 -1.01 % $ 1.68 B usaUSA
Replimune Group Replimune Group
REPL
58.2 M $ 19.07 -0.83 % $ 1.77 B usaUSA
NextCure NextCure
NXTC
6.41 M $ 6.62 -2.43 % $ 35.2 M usaUSA
Rocket Pharmaceuticals Rocket Pharmaceuticals
RCKT
30.2 M $ 1.95 -7.82 % $ 217 M usaUSA
PMV Pharmaceuticals PMV Pharmaceuticals
PMVP
11.4 M $ 0.87 -33.79 % $ 45.7 M usaUSA
United Therapeutics Corporation United Therapeutics Corporation
UTHR
561 M $ 553.08 -1.08 % $ 24.5 B usaUSA
Olema Pharmaceuticals Olema Pharmaceuticals
OLMA
51.8 M $ 7.0 -2.1 % $ 609 M usaUSA
Kymera Therapeutics Kymera Therapeutics
KYMR
83.2 M $ 115.19 -3.52 % $ 9.73 B usaUSA
Oragenics Oragenics
OGEN
1.8 M $ 0.16 -6.16 % $ 345 K usaUSA
Ovid Therapeutics Ovid Therapeutics
OVID
8.29 M $ 2.2 -5.98 % $ 286 M usaUSA
Passage Bio Passage Bio
PASG
20.7 M $ 3.94 9.14 % $ 12.6 M usaUSA
Vaxcyte Vaxcyte
PCVX
206 M $ 55.37 -5.12 % $ 7.54 B usaUSA
Relay Therapeutics Relay Therapeutics
RLAY
25.6 M $ 16.11 1.26 % $ 2.76 B usaUSA
Precigen Precigen
PGEN
37.3 M $ 4.21 1.08 % $ 1.32 B usaUSA
Avidity Biosciences Avidity Biosciences
RNA
195 M $ 6.94 -0.57 % $ 956 M usaUSA
Phio Pharmaceuticals Corp. Phio Pharmaceuticals Corp.
PHIO
1.02 M $ 0.66 -7.55 % $ 3.95 M usaUSA
Praxis Precision Medicines Praxis Precision Medicines
PRAX
59.8 M $ 300.01 -3.5 % $ 6.75 B usaUSA
Prelude Therapeutics Incorporated Prelude Therapeutics Incorporated
PRLD
53 M $ 3.22 -1.08 % $ 248 M usaUSA
Ocular Therapeutix Ocular Therapeutix
OCUL
50.8 M $ 5.57 -5.03 % $ 1.04 B usaUSA
Sana Biotechnology Sana Biotechnology
SANA
78.7 M $ 1.58 -9.2 % $ 400 M usaUSA